Soleno Shares Are Up Today: What’s Going On?

Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares are trading higher Thursday after the company announced it secured FDA approval for its first commercial drug, Vykat XR (diazoxide choline) extended-release tablets.

Money isn’t everything. Let’s talk about what makes life worth living

China Set to Announce Major Fiscal Stimulus Amid U.S. Policy Shifts Under Trump

LinkedIn SEO: The Ultimate Guide to Maximizing Your Professional Visibility in 2024

Trump’s Provocative Rhetoric Fuels Gender Dynamics

Meta’s Bullish Report: AI Drives Q3 Growth

Analysts Ratings: Here Are Top 5 Downgrades For Wednesday

Bitcoin Could Hit $101,694 By January, Says 10x Research

10 Proven Ways to Make Money Online in 2024: A Beginner’s Guide

Tesla’s Semi Truck Rollout and Charging Infrastructure Challenges

How are AI investments leading to mass layoffs in tech?

Genmo’s Mochi 1: Revolutionizing AI Video Generation with Open-Source Access

Tech Industry Jobs: AI’s Impact on Tech Workforce

If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today

Gene Therapy-Focused Bluebird Bio Receives Rival Takeover Offer, Stock Jumps

Trump Media To Begin Trading On NYSE Texas With DJT Ticker Amid Stock Slump

Siemens, Accenture Deepen Alliance With New Business Group Targeting AI-Driven Engineering

A Closer Look at Carvana’s Options Market Dynamics

Smart Money Is Betting Big In LULU Options